In vivo and in vitro expression of the RASAL1 gene in human gastric adenocarcinoma and its clinicopathological significance

  • Authors:
    • Hong Chen
    • Xiao-Wei Yang
    • Hui Zhang
    • Qing Yang
    • Zhi Wang
    • Yang  Liu
    • Feng-Lin Lu
    • Bao-Yi Zhou
    • Cheng-Hui Qiu-Xi
    • Sheng-Lin Lu
  • View Affiliations

  • Published online on: December 6, 2011     https://doi.org/10.3892/ol.2011.513
  • Pages: 535-540
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Recent studies have suggested that the RAS protein activator like-1 (RASAL1) is a potential tumor suppressor, which is found to be reduced in certain human cancers. Its downregulation is involved in the progression of malignancies. However, whether or not RASAL1 plays a role in the development of gastric cancer remains to be determined. Our study aimed to clarify the role of RASAL1 in the progression of gastric adenocarcinoma. The expression of RASAL1 in primary gastric adenocarcinoma tissue specimens was determined by immunohistochemistry. The expression of RASAL1 mRNA and protein was detected by RT-PCR and western blotting in gastric adenocarcinoma cell lines with varying differentiation statuses, including well‑differentiated MKN-28, moderately differentiated SGC-7901 and poorly differentiated BGC-823, respectively. A normal gastric epithelial cell line, GES-l, was used as the control line. The immunohistochemical results revealed that the expression of the RASAL1 protein was mainly observed in the cytoplasm. Among 50 cases of gastric adenocarcinoma tissues, 12 cases were identified as (-), 23 cases (+), 13 cases (++) and 2 cases (+++). Among 50 cases of normal gastric tissues, 16 cases were (++) and 34 cases (+++). The expression of the RASAL1 protein was found to be decreased in the gastric adenocarcinoma tissue compared with normal gastric tissue (p<0.01). Moreover, in the gastric carcinoma tissues, the expression of RASAL1 was correlated with carcinoma diameter, differentiation grades, invasive depth, lymph node metastasis and TNM. Additionally, the RASAL1 mRNA and proteins were decreased in the three gastric adenocarcinoma cell lines compared with the normal gastric epithelial cell line GES-l. In addition, the downregulation of RASAL1 correlated with the differentiation status of cancer cell lines. Based on the above investigation, we conclude that expression of the RASAL1 gene is decreased in gastric carcinoma tissues and cell lines. The results indicate that RASAL1 may be important in the tumorigenesis and development of gastric carcinoma.
View Figures
View References

Related Articles

Journal Cover

March 2012
Volume 3 Issue 3

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Chen H, Yang X, Zhang H, Yang Q, Wang Z, Liu Y, Lu F, Zhou B, Qiu-Xi C, Lu S, Lu S, et al: In vivo and in vitro expression of the RASAL1 gene in human gastric adenocarcinoma and its clinicopathological significance. Oncol Lett 3: 535-540, 2012
APA
Chen, H., Yang, X., Zhang, H., Yang, Q., Wang, Z., Liu, Y. ... Lu, S. (2012). In vivo and in vitro expression of the RASAL1 gene in human gastric adenocarcinoma and its clinicopathological significance. Oncology Letters, 3, 535-540. https://doi.org/10.3892/ol.2011.513
MLA
Chen, H., Yang, X., Zhang, H., Yang, Q., Wang, Z., Liu, Y., Lu, F., Zhou, B., Qiu-Xi, C., Lu, S."In vivo and in vitro expression of the RASAL1 gene in human gastric adenocarcinoma and its clinicopathological significance". Oncology Letters 3.3 (2012): 535-540.
Chicago
Chen, H., Yang, X., Zhang, H., Yang, Q., Wang, Z., Liu, Y., Lu, F., Zhou, B., Qiu-Xi, C., Lu, S."In vivo and in vitro expression of the RASAL1 gene in human gastric adenocarcinoma and its clinicopathological significance". Oncology Letters 3, no. 3 (2012): 535-540. https://doi.org/10.3892/ol.2011.513